Yoh Yokota

Department Of Otorhinolaryngology Head And Neck Surgery, 3-1-1 Asahi
Matsumoto, 3908621, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Age-stratified clinical interpretation of AWGS2025 sarcopenia criteria in head and neck cancer treated with definitive chemoradiotherapy: Comparison with AWGS2019.

Age-stratified clinical interpretation of AWGS2025 sarcopenia criteria in head and neck cancer treated with definitive chemoradiotherapy: Comparison with AWGS2019.

Journal: Auris, nasus, larynx

Published: March 30, 2026

Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study.

Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study.

Journal: Anticancer research

Published: November 23, 2025

Long-term Outcomes and Mixed Response in Nivolumab Therapy for Head and Neck Cancer.

Long-term Outcomes and Mixed Response in Nivolumab Therapy for Head and Neck Cancer.

Journal: In vivo (Athens, Greece)

Published: May 11, 2025

Post-treatment Neutrophil/Lymphocyte Ratio Is a Prognostic Factor in Head and Neck Cancers Treated With Nivolumab.

Post-treatment Neutrophil/Lymphocyte Ratio Is a Prognostic Factor in Head and Neck Cancers Treated With Nivolumab.

Journal: Cancer diagnosis & prognosis

Published: November 28, 2023

A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy.

A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy.

Journal: Biomolecules

Published: October 01, 2023

Prognostic significance of pre- and post-treatment hematological biomarkers in patients with head and neck cancer treated with chemoradiotherapy.

Prognostic significance of pre- and post-treatment hematological biomarkers in patients with head and neck cancer treated with chemoradiotherapy.

Journal: Scientific reports

Published: September 13, 2022

Impact of Low Skeletal Muscle Mass on the Prognosis of Patients with Head and Neck Cancer Treated Nonsurgically.

Impact of Low Skeletal Muscle Mass on the Prognosis of Patients with Head and Neck Cancer Treated Nonsurgically.

Journal: ORL; journal for oto-rhino-laryngology and its related specialties

Published: June 14, 2022

Perioperative management of a patient with a giant thyroglossal duct cyst: a case report.

Perioperative management of a patient with a giant thyroglossal duct cyst: a case report.

Journal: Journal of surgical case reports

Published: May 11, 2022

Factors Affecting Nivolumab Therapy Outcome in Patients with Head and Neck Cancer: A Single-Center Analysis.

Factors Affecting Nivolumab Therapy Outcome in Patients with Head and Neck Cancer: A Single-Center Analysis.

Journal: Oncology

Published: December 02, 2021

Frequency and clinical features of hearing loss caused by STRC deletions.

Frequency and clinical features of hearing loss caused by STRC deletions.

Journal: Scientific reports

Published: October 27, 2018

Diagnostic pitfalls for GJB2-related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss.

Diagnostic pitfalls for GJB2-related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss.

Journal: Clinical case reports

Published: June 26, 2018

Etiology of single-sided deafness and asymmetrical hearing loss.

Etiology of single-sided deafness and asymmetrical hearing loss.

Journal: Acta oto-laryngologica

Published: April 04, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026